Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Galimberti

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Tumori|January 31, 1998
[Treatment of multidrug resistance in oncology and hematology]M Petrini, S Galimberti
Cancer Management and Research|December 29, 2010
Temsirolimus in the treatment of relapsed and/or refractory mantle cell lymphomaS Galimberti, M Petrini
Journal of Chemotherapy (Florence, Italy)|September 10, 2003
Early reappearance of primary solid cancer in patients treated with purine analogsR Fazzi, F Caracciolo, S Galimberti, et al.
Leukemia Research|November 26, 1999
An advantageous method to evaluate IgH rearrangement and its role in minimal residual disease detectionS Galimberti, F Brizzi, M Mameli, et al.
Haematologica|January 1, 1997
c-Jun and GST-pi expression in human plasma cellsD Di Simone, S Galimberti, L Mattii, et al.
Journal of Chemotherapy (Florence, Italy)|September 10, 2003
The clinical relevance of the expression of several multidrug-resistant-related genes in patients with primary acute myeloid leukemiaS Galimberti, R Testi, F Guerrini, et al.
Hematological Oncology|January 22, 2004
Low dose 2-CdA schedule activity in splenic marginal zone lymphomasR Riccioni, F Caracciolo, S Galimberti, et al.
Journal of Chemotherapy (Florence, Italy)|August 31, 2004
Role of low-dose 2-CdA in refractory or resistant lymphoplasmocytic lymphomaG Cervetti, S Galimberti, N Cecconi, et al.
Annals of Hematology|March 10, 2001
Interferon-alpha activity in a case of severe autoimmune lymphoproliferative diseaseS Ceretelli, M Petrini, S Galimberti, et al.
Clinical and Experimental Rheumatology|January 7, 2006
High efficacy of Rituximab in indolent HCV-related lymphoproliferative disorders associated with systemic autoimmune diseasesG Cervetti, S Mechelli, R Riccioni, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Tumori|January 31, 1998
[Treatment of multidrug resistance in oncology and hematology]M Petrini, S Galimberti
Cancer Management and Research|December 29, 2010
Temsirolimus in the treatment of relapsed and/or refractory mantle cell lymphomaS Galimberti, M Petrini
Journal of Chemotherapy (Florence, Italy)|September 10, 2003
Early reappearance of primary solid cancer in patients treated with purine analogsR Fazzi, F Caracciolo, S Galimberti, et al.
Leukemia Research|November 26, 1999
An advantageous method to evaluate IgH rearrangement and its role in minimal residual disease detectionS Galimberti, F Brizzi, M Mameli, et al.
Haematologica|January 1, 1997
c-Jun and GST-pi expression in human plasma cellsD Di Simone, S Galimberti, L Mattii, et al.
Journal of Chemotherapy (Florence, Italy)|September 10, 2003
The clinical relevance of the expression of several multidrug-resistant-related genes in patients with primary acute myeloid leukemiaS Galimberti, R Testi, F Guerrini, et al.
Hematological Oncology|January 22, 2004
Low dose 2-CdA schedule activity in splenic marginal zone lymphomasR Riccioni, F Caracciolo, S Galimberti, et al.
Journal of Chemotherapy (Florence, Italy)|August 31, 2004
Role of low-dose 2-CdA in refractory or resistant lymphoplasmocytic lymphomaG Cervetti, S Galimberti, N Cecconi, et al.
Annals of Hematology|March 10, 2001
Interferon-alpha activity in a case of severe autoimmune lymphoproliferative diseaseS Ceretelli, M Petrini, S Galimberti, et al.
Clinical and Experimental Rheumatology|January 7, 2006
High efficacy of Rituximab in indolent HCV-related lymphoproliferative disorders associated with systemic autoimmune diseasesG Cervetti, S Mechelli, R Riccioni, et al.
Pageof 7